Related Experiment Video
Updated: Aug 14, 2026

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
Published on: July 2, 2013
[Gentacycol--a delayed-action form of gentamicin in the treatment of suppurative infection]
Abstract:
Efficacy of gentacycol was studied in the treatment of various purulent infections. It was used in therapy of hematogenic and traumatic osteomyelitis, wound infections, soft tissue abscesses, purulent diffuse peritonitis as a complication of comissural ileus or appendectomy, pyothorax, destructive pneumonia and mediastinitis. Gentacycol ++ was also used for the prophylaxis in cholecystectomy, herniotomy and other conditions. The favourable results were stated in 93 per cent of the cases.
Insights
Gentacycol demonstrated high efficacy in treating numerous purulent infections, including osteomyelitis and abscesses. This antibiotic achieved favorable outcomes in 93% of cases, highlighting its effectiveness in diverse clinical scenarios.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Antibiotic Therapy
Background:
- Purulent infections pose significant clinical challenges.
- Effective treatment options are crucial for patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of gentacycol in treating various purulent infections.
- To assess gentacycol's utility in both treatment and prophylaxis.
Main Methods:
- Clinical study of gentacycol's application.
- Therapeutic use in conditions like osteomyelitis, wound infections, and peritonitis.
- Prophylactic use in surgical procedures.
Main Results:
- Gentacycol was effective in treating a wide range of purulent infections.
- Favorable results were observed in 93% of treated cases.
- Successful prophylactic application in various surgical interventions.
Conclusions:
- Gentacycol is a highly effective agent for managing purulent infections.
- Its broad spectrum of activity supports its use in both treatment and prevention.
- The high success rate indicates significant clinical value.
Related Concept Videos
Tonsillitis II: Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Urinary Tract Infection IV: Nursing Management

